HAI Book 2025 - Flipbook - Page 660
Conclusions: Our results support that AA-2024 biological and clinical stages show reasonable concordance using
either Flortaucipir or MK-6240, although this can vary based on methods used in the analyses. The MBI and SCD
transition groups showed more similar pathological burden to clinical stage 1 than to the SOCD transitional stage
2.
Keywords: Tau PET, Alzheimer’s disease, biological staging, clinical stages, concordance
HAI2025 - 660
